Описание
Phenytoin induces hepatic CYP enzymes that increase the formation of acetaminophen's toxic metabolite NAPQI, raising hepatotoxicity risk; conversely, large doses of acetaminophen may transiently reduce phenytoin levels.
Механизм
Phenytoin induces CYP2E1 and CYP3A4, augmenting toxic NAPQI production from acetaminophen while reducing glucuronidation; high-dose acetaminophen may also compete for CYP2C9 sites involved in phenytoin hydroxylation.
Клиническое значение
Chronic phenytoin therapy significantly increases acetaminophen hepatotoxicity risk; acute phenytoin changes in patients receiving analgesic doses are less predictable.
Тактика ведения
Limit acetaminophen dose and duration in patients on phenytoin; monitor liver function tests if prolonged co-administration is unavoidable.
Медицинский отказ от ответственности
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.